NorthWest Biotherapeutics Inc (NWBO)

[anders2211]

Beartrap,

No it does not work like that.

When a biotech starts a trial they will ask the FDA for permission to start the trial and with that, they will state the aimed endpoints the biotech company aims to achieve. If the FDA approves the start of a new biotech trial the company knows what the endpoints are which it needs to achieve in order to get approved. These are in most cases an improvement of current SOC. If a biotech does not change its aimed endpoints, some call it ad hoc changing goalposts after results are in like NWNO did, investors/analyst can then when TLD is in fairly easy estimate wheater the given results have met the first obtained and FDA approved trial endpoints.

NWBO CHANGED the endpoints they wanted to achieve most probably from PFS to OS. That is why undeniable they all over sudden announced they were working on a NEW SAP multi months last year. We don't know for sure if the FDA will be inclined to approve based on the TLD no matter how wonderful. The reason for this is because the TLD has been submitted recently and changed from the beginning when the trial started.
Had NWBO submitted the new SAP at the beginning of the trial and was the trail approved, then it would have been much easier for analysts after TLD to estimate wheater it will be approved or now. Now not so.

Statements from Les are Disney statements, it's a wonderful world always all the time and one should perceive his statements in that manner, Disney...